Raungrut, P.; Tanyapattrapong, S.; Masjon, T.; Maungchanburi, S.; Thongsuksai, P.
Transcriptomic Profiling of Carboplatin- and Paclitaxel-Resistant Lung Adenocarcinoma Cells Reveals CSF3 as a Potential Biomarker for the Carboplatin Plus Paclitaxel Doublet Regimens. Curr. Issues Mol. Biol. 2024, 46, 13951-13969.
https://doi.org/10.3390/cimb46120834
AMA Style
Raungrut P, Tanyapattrapong S, Masjon T, Maungchanburi S, Thongsuksai P.
Transcriptomic Profiling of Carboplatin- and Paclitaxel-Resistant Lung Adenocarcinoma Cells Reveals CSF3 as a Potential Biomarker for the Carboplatin Plus Paclitaxel Doublet Regimens. Current Issues in Molecular Biology. 2024; 46(12):13951-13969.
https://doi.org/10.3390/cimb46120834
Chicago/Turabian Style
Raungrut, Pritsana, Suchanan Tanyapattrapong, Thipphanet Masjon, Saowanee Maungchanburi, and Paramee Thongsuksai.
2024. "Transcriptomic Profiling of Carboplatin- and Paclitaxel-Resistant Lung Adenocarcinoma Cells Reveals CSF3 as a Potential Biomarker for the Carboplatin Plus Paclitaxel Doublet Regimens" Current Issues in Molecular Biology 46, no. 12: 13951-13969.
https://doi.org/10.3390/cimb46120834
APA Style
Raungrut, P., Tanyapattrapong, S., Masjon, T., Maungchanburi, S., & Thongsuksai, P.
(2024). Transcriptomic Profiling of Carboplatin- and Paclitaxel-Resistant Lung Adenocarcinoma Cells Reveals CSF3 as a Potential Biomarker for the Carboplatin Plus Paclitaxel Doublet Regimens. Current Issues in Molecular Biology, 46(12), 13951-13969.
https://doi.org/10.3390/cimb46120834
